Puratifomu yeDTP yeCaryHealth inoita kuti nzira yekurapa Natroba (echinococcin) ive nyore nekutsiva nzira dzakasiyana dzekutarisira varwere kuburikidza nekushandisa nzira isina musono, inotarisa varwere.
WASHINGTON, Kubvumbi 7, 2026 — (BUSINESS WIRE) — CaryHealth, kambani inotungamira yehutano hwedhijitari, nhasi yazivisa kubatana neCipher Pharmaceuticals US LLC (Cipher kana Cipher Pharmaceuticals) kuti vatange puratifomu yavo yekuenda kumurwere zvakananga (DTP), yakagadzirirwa kupa varwere mukana uri nyore wekushandisa mushonga weNatroba (spinosad), unoshandiswa kurapa inda dzemusoro nemakwekwe. Sechikamu chekubatana uku, CaryHealth yakagadzira puratifomu yepamhepo yakagadzirirwa varwere kuti vakwanise kuwana nekukurumidza uye kutora Natroba (spinosad), ichibvisa zvipingamupinyi zvinowanzosangana nevarwere pavanenge vachishandisa masevhisi ehutano ari paindaneti.
"Mhuri dzine inda neganda dzinoda mhinduro inokurumidza uye iri nyore yekuwana mishonga yakanakisa uye inoshanda zvakanyanya," akadaro Brian Jacobs, Mutungamiriri weUS Operations for Cipher Pharmaceuticals. "Kuburikidza nekubatana kwedu neCaryHealth, tinopa nzira yekutora mishonga kana kuiendesa kumba, zvichiita kuti zvive nyore uye nekukurumidza kuti varwere vawane Natroba™ kana kuti spinosad. Mishonga yechinyakare yemishonga haisisiri kushanda, asi Natroba™ (spinosad) inopihwa mushonga inopa zororo nekukurumidza kubva kunda neganda."
"Cipher iri kutora danho rakasimba, rinotarisa varwere nekudyara mumhando yehutano hwedhijitari yakabatana," akadaro Areo Nazari, CEO weCaryHealth. "Nekubatanidza mishonga inonyorerwa, kutaurirana nachiremba, uye masevhisi emishonga (kusanganisira kuendesa) muchiitiko chimwe chete, tinogona kubatsira mhuri kudzokera kune zvakajairika, kubva panguva yavanotsvaga rubatsiro kusvika panguva yavanorapa zvinobudirira."
CaryHealth yakagadzira mhinduro yakabatana, isina musono, uye yakazara yekutarisira varwere zvakananga kuNatroba™ (echinococcin), ichivandudza ruzivo rwese rwekutarisira nekuderedza nguva yekuwana uye kubvisa zvipingamupinyi. Mhinduro iyi inobvisa maitiro ekutarisira epamhepo asina kubatana, kupinda mukati kakawanda, uye matanho ekubhadhara akasiyana, zvichibvumira varwere kugamuchira mishonga inorapwa zvakanaka vari kure, kunakidzwa nekutumira mishonga yezuva rimwe chete kubva kumishonga munyika yese munzvimbo yebasa reCaryRx, uye kuteedzera mamiriro emishonga panguva chaiyo kuburikidza neCaryConnect portal.
CaryHealth ikambani yedhijitari yemishonga nehutano inoshandisa hungwaru hwekugadzira kushandura maitiro evarwere ekutanga uye kutevedzera kurapwa. Puratifomu yedu inobatanidza masevhisi emishonga, otomatiki yakangwara, uye kubatanidzwa kunotungamirirwa nedata kuti ivandudze maitiro ehutano, kuvandudza kuenderera mberi kwekurapwa, uye kupa simba varwere panguva yese yekurapwa. Nekubatanidza musiyano uripo pakati pesainzi yehupenyu, vanopa hutano, nevarwere, CaryHealth inokurudzira mukana wakaenzana wekuwana zviwanikwa zvehutano uye inobatsira kurapwa kwakasiyana-siyana kusvika pakukwanisa kwavo kwakazara.
Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) ikambani yemishonga yakatarisana nekurapa kweganda ine huwandu hwakawanda uye hwakasiyana hwezvigadzirwa nezvigadzirwa zvinotengeswa pakutanga uye pakupera kwekukura. Cipher topical Natroba™ uye rezinesi rayo rejisiti, spinosad, ndizvo zvigadzirwa chete zvakawana "chiratidzo chakajeka" cheganda kubva kuUS Food and Drug Administration (FDA). Pamusoro pezvo, Natroba™ (spinosad) ndiyo yega mushonga unobvumidzwa neFDA wekurapa inda dzemusoro wakaratidza kushanda kwakanaka kwekiriniki zvichienzaniswa neNix® (1% permethrin) mumiedzo miviri yekiriniki yePhase III. Hapana kukwesha mazai enda zvinodiwa.
Nguva yekutumira: Kubvumbi-28-2026
